Analyst consensus rating
Charles River Laboratories International Analyst Rating: Buy
Direct answer
Charles River Laboratories International's consensus rating is Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $281.00.
Forecast evidence checked September 7, 2026.
Get free Charles River Laboratories International email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $288.50
- Average price target
- $281.00
- High price target
- $318.00
- Low price target
- $145.00
- Low target gap
- -49.7%
- Target upside
- -2.6%
- High target gap
- +10.2%
- Target range width
- 60%
- Consensus rating
- Buy
- Analysts
- 14
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Charles River Laboratories International?
Charles River Laboratories International has a verified Buy consensus. The same dataset has an average price target of $281.00.
How far are Charles River Laboratories International's low and high targets from the recorded price?
The low target implies -49.7%, while the high target implies +10.2%.
How many analysts are included in Charles River Laboratories International's consensus?
The verified consensus includes 14 analysts.
How is Charles River Laboratories International's target upside or downside calculated?
The average target of $281.00 is divided by the recorded price of $288.50, then one is subtracted to produce -2.6%. This does not guarantee a future return.
When was Charles River Laboratories International's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.